Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis
Montalban, Xavier, Arnold, Douglas L, Weber, Martin S, Staikov, Ivan, Piasecka-Stryczynska, Karolina, Willmer, Jonathan, Martin, Emily C, Dangond, Fernando, Syed, Sana, Wolinsky, Jerry S
Published in The New England journal of medicine (20.06.2019)
Published in The New England journal of medicine (20.06.2019)
Get full text
Journal Article
Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Adeniji, Abidemi K, Vermersch, Patrick
Published in Multiple sclerosis (01.10.2018)
Published in Multiple sclerosis (01.10.2018)
Get full text
Journal Article
Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers
Stuve, Olaf, Soelberg Soerensen, Per, Leist, Thomas, Giovannoni, Gavin, Hyvert, Yann, Damian, Doris, Dangond, Fernando, Boschert, Ursula
Published in Therapeutic advances in neurological disorders (01.06.2019)
Published in Therapeutic advances in neurological disorders (01.06.2019)
Get full text
Journal Article
Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies
De Stefano, Nicola, Sormani, Maria Pia, Giovannoni, Gavin, Rammohan, Kottil, Leist, Thomas, Coyle, Patricia K, Dangond, Fernando, Keller, Birgit, Alexandri, Nektaria, Galazka, Andrew
Published in Multiple sclerosis (01.01.2022)
Published in Multiple sclerosis (01.01.2022)
Get full text
Journal Article
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
De Stefano, Nicola, Giorgio, Antonio, Battaglini, Marco, De Leucio, Alessandro, Hicking, Christine, Dangond, Fernando, Giovannoni, Gavin, Sormani, Maria Pia
Published in Multiple sclerosis (01.02.2018)
Published in Multiple sclerosis (01.02.2018)
Get full text
Journal Article
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study
Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil W, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Hicking, Christine, Vermersch, Patrick
Published in Multiple sclerosis (01.05.2019)
Published in Multiple sclerosis (01.05.2019)
Get full text
Journal Article
Determination of a clinically effective evobrutinib dose: Exposure–response analyses of a phase II relapsing multiple sclerosis study
Papasouliotis, Orestis, Mitchell, David, Girard, Pascal, Dangond, Fernando, Dyroff, Martin
Published in Clinical and translational science (01.12.2022)
Published in Clinical and translational science (01.12.2022)
Get full text
Journal Article
Facing the urgency of therapies for progressive MS — a Progressive MS Alliance proposal
Dangond, Fernando, Donnelly, Alexis, Hohlfeld, Reinhard, Lubetzki, Catherine, Kohlhaas, Susan, Leocani, Letizia, Ciccarelli, Olga, Stankoff, Bruno, Sormani, Maria Pia, Chataway, Jeremy, Bozzoli, Federico, Cucca, Francesco, Melton, Lisa, Coetzee, Timothy, Salvetti, Marco
Published in Nature reviews. Neurology (01.03.2021)
Published in Nature reviews. Neurology (01.03.2021)
Get full text
Journal Article
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin
Published in Therapeutic advances in neurological disorders (01.01.2018)
Published in Therapeutic advances in neurological disorders (01.01.2018)
Get full text
Journal Article
Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS
Freedman, Mark S., Brod, Staley, Singer, Barry A., Cohen, Bruce A., Hayward, Brooke, Dangond, Fernando, Coyle, Patricia K.
Published in Journal of neurology (2020)
Published in Journal of neurology (2020)
Get full text
Journal Article
Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing-remitting multiple sclerosis at year 1
Traboulsee, Anthony, Li, David K B, Cascione, Mark, Fang, Juanzhi, Dangond, Fernando, Miller, Aaron
Published in BMC neurology (14.09.2018)
Published in BMC neurology (14.09.2018)
Get full text
Journal Article
Sodium phenylbutyrate prolongs survival and regulates expression of anti‐apoptotic genes in transgenic amyotrophic lateral sclerosis mice
Ryu, Hoon, Smith, Karen, Camelo, Sandra I., Carreras, Isabel, Lee, Junghee, Iglesias, Antonio H., Dangond, Fernando, Cormier, Kerry A., Cudkowicz, Merit E., H. Brown, Robert, Ferrante, Robert J.
Published in Journal of neurochemistry (01.06.2005)
Published in Journal of neurochemistry (01.06.2005)
Get full text
Journal Article
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives
Freedman, Mark S., Coyle, Patricia K., Hellwig, Kerstin, Singer, Barry, Wynn, Daniel, Weinstock-Guttman, Bianca, Markovic-Plese, Silva, Galazka, Andrew, Dangond, Fernando, Korich, Julie, Reder, Anthony T.
Published in Neurology and therapy (01.04.2024)
Published in Neurology and therapy (01.04.2024)
Get full text
Journal Article
Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis
Oh, Jiwon, Walker, Bryan, Giovannoni, Gavin, Jack, Dominic, Dangond, Fernando, Nolting, Axel, Aldridge, Julie, Lebson, Lori A, Leist, Thomas P
Published in Multiple sclerosis journal - experimental, translational and clinical (01.07.2021)
Published in Multiple sclerosis journal - experimental, translational and clinical (01.07.2021)
Get full text
Journal Article
Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study
Traboulsee, Anthony, Li, David K B, Cascione, Mark, Fang, Juanzhi, Dangond, Fernando, Miller, Aaron
Published in BMC neurology (11.05.2018)
Published in BMC neurology (11.05.2018)
Get full text
Journal Article
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study
Zivadinov, Robert, Dwyer, Michael G, Markovic-Plese, Silva, Kennedy, Cheryl, Bergsland, Niels, Ramasamy, Deepa P, Durfee, Jacqueline, Hojnacki, David, Hayward, Brooke, Dangond, Fernando, Weinstock-Guttman, Bianca
Published in PloS one (13.03.2014)
Published in PloS one (13.03.2014)
Get full text
Journal Article
The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study
Freedman, Mark S, Leist, Thomas P, Comi, Giancarlo, Cree, Bruce AC, Coyle, Patricia K, Hartung, Hans-Peter, Vermersch, Patrick, Damian, Doris, Dangond, Fernando
Published in Multiple sclerosis journal - experimental, translational and clinical (01.10.2017)
Published in Multiple sclerosis journal - experimental, translational and clinical (01.10.2017)
Get full text
Journal Article
Functional Characterization of JMJD2A, a Histone Deacetylase- and Retinoblastoma-binding Protein
Gray, Steven G, Iglesias, Antonio H, Lizcano, Fernando, Villanueva, Raul, Camelo, Sandra, Jingu, Hisaka, Teh, Bin T, Koibuchi, Noriyuki, Chin, William W, Kokkotou, Efi, Dangond, Fernando
Published in The Journal of biological chemistry (05.08.2005)
Published in The Journal of biological chemistry (05.08.2005)
Get full text
Journal Article
Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study
Freedman, Mark S, Coyle, Patricia K, Comi, Giancarlo, L Scarberry, Susan, Damian, Doris, Hyvert, Yann, Dangond, Fernando, Galazka, Andrew, Jack, Dominic, Lebson, Lori A, Leist, Thomas P
Published in Multiple sclerosis journal - experimental, translational and clinical (2021)
Published in Multiple sclerosis journal - experimental, translational and clinical (2021)
Get full text
Journal Article